SHINE Medical Technologies
Janesville, US · Founded 2010 · Delaware corporation · 6 known investors
Find your way into SHINE Medical Technologies
ShineMed pursues a step-by-step commercialization approach to fusion energy, aiming to prove market value at each stage while generating revenue toward the goal of clean, abundant fusion power.
Founders & leadership
SHINE Medical Technologies was founded in 2010 by Gregory Richard Piefer.
GR
Gregory Richard PieferFounder
KP
Katrina PitasExecutive
DJ
Darin JanecekExecutive
AA
Anton AsmuthExecutive
JC
James CostedioExecutive
DA
David A. WeissburginExecutive
SC
Stephen Clermont HathawayExecutive
Board
TR

Thomas Rockwell MackieBoard directorAdvisory Board/Emeritus at Wisconsin Investment Partners
RH

Richard H. LeazerBoard directorFounder, Advisory Board/Emeritus at Wisconsin Investment Partners
PM
Philip M. HalpernBoard director
FM
Fred MancheskiBoard director
DW
Donald WhelleyBoard director
Investors · 6
Venture ManagementMadison
Wisconsin Investment PartnersMadison · $5K – $100K
Baillie GiffordreportedEdinburgh
Deerfield Management CompanyreportedNew York
Koch Disruptive TechnologiesreportedSan Francisco
Also in the syndicate · 1
Fidelity Management and Research Co.
Reported raises · per SEC filings
Form D private placements$77.7M disclosed across 5 of 7 rounds · 2010–2021
▶$18.1MraisedJun 2019 · 99 investors · Other Health CareRule 506(b)
▶$18.1MraisedJun 2019 · 99 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Brad WucherpfennigDirector
- Gordon GunnlaugssonDirector
- Gregory SmithDirector
- Anton AsmuthExecutive Officer, Director
- Philip M. HalpernDirector
- Thomas Rockwell MackieDirector
- Gregory Richard PieferExecutive Officer, Director
- Steve MiltenbergerExecutive Officer
- Katrina PitasExecutive Officer
- Harsh SinghExecutive Officer
- Offering amount
- $30M
- Amount sold
- $18.1M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$18MraisedNov 2018 · 122 investors · Other Health CareRule 506(b)
▶$18MraisedNov 2018 · 122 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Steve MiltenbergerExecutive Officer
- Gregory Richard PieferExecutive Officer, Director
- Gregory SmithDirector
- Philip M. HalpernDirector
- Anton AsmuthExecutive Officer, Director
- Gordon GunnlaugssonDirector
- Thomas Rockwell MackieDirector
- Brad WucherpfennigDirector
- Offering amount
- $24.6M
- Amount sold
- $18M
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.9MraisedSep 2017 · 26 investors · Other Health CareRule 506(b)
▶$6.9MraisedSep 2017 · 26 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Donald WhelleyDirector
- Philip M. HalpernDirector
- Gregory SmithDirector
- Darin JanecekExecutive Officer
- Anton AsmuthExecutive Officer, Director
- Thomas Rockwell MackieDirector
- Richard H. LeazerDirector
- Gregory Richard PieferExecutive Officer, Director
- Offering amount
- $15.5M
- Amount sold
- $6.9M
- Sales commissions
- $155K
- Placement agents
- Piper Jaffray & Co.
- First sale
- Aug 2017
- Incorporated
- Corporation, Wisconsin
- Federal exemptions
- 06b
▶$29.3MraisedApr 2017 · 217 investors · Other Health CareRule 506(b)
▶$29.3MraisedApr 2017 · 217 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thomas Rockwell MackieDirector
- Katrina PitasExecutive Officer
- Darin JanecekExecutive Officer
- Richard H. LeazerDirector
- Donald WhelleyDirector
- Philip M. HalpernDirector
- Gregory Richard PieferExecutive Officer, Director
- Anton AsmuthExecutive Officer, Director
- James CostedioExecutive Officer
- Offering amount
- $30M
- Amount sold
- $29.3M
- Sales commissions
- $300K
- Placement agents
- Piper Jaffray & Co.
- First sale
- Oct 2013
- Incorporated
- Corporation, Wisconsin
- Federal exemptions
- 06b
▶$5.4MraisedMar 2012 · 15 investors · Other Health CareRule 506(b)
▶$5.4MraisedMar 2012 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David A. WeissburgExecutive Officer, Director, Promoter
- Gregory Richard PieferExecutive Officer, Director, Promoter
- Fred MancheskiDirector
- Donald WhelleyDirector
- Richard H. LeazerDirector
- Thomas Rockwell MackieDirector
- Richard Vann BynumDirector
- Stephen Clermont HathawayExecutive Officer, Promoter
- Offering amount
- $11.4M
- Amount sold
- $5.4M
- Proceeds to insiders
- $256.3K
- First sale
- Dec 2010
- Incorporated
- Corporation, Wisconsin, 2010
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does SHINE Medical Technologies do?
- ShineMed pursues a step-by-step commercialization approach to fusion energy, aiming to prove market value at each stage while generating revenue toward the goal of clean, abundant fusion power.
- Who founded SHINE Medical Technologies?
- SHINE Medical Technologies was founded by Gregory Richard Piefer in 2010.
- Who are SHINE Medical Technologies's investors?
- SHINE Medical Technologies's investors include Venture Management, Wisconsin Investment Partners, Baillie Gifford, Deerfield Management Company, Koch Disruptive Technologies.
- How much funding has SHINE Medical Technologies raised?
- SHINE Medical Technologies has disclosed $77.7M raised across 5 of its 7 known rounds.
- Where is SHINE Medical Technologies headquartered?
- SHINE Medical Technologies is headquartered in Janesville, US.
